Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Guggenheim

BioMarin Pharmaceutical Inc.
Start price
€94.17
28.02.23 / 50%
Target price
€117.80
28.02.24
Performance (%)
-13.41%
End price
€81.54
29.02.24
Summary
This prediction ended on 29.02.24 with a price of €81.54. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -13.41%. Guggenheim has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioMarin Pharmaceutical Inc. -7.208% -7.208% -9.264%
iShares Core DAX® -1.611% 3.135% 15.880%
iShares Nasdaq 100 -0.500% 0.775% 20.054%
iShares Nikkei 225® -1.483% 4.610% 11.154%
iShares S&P 500 -0.501% 1.914% 21.016%

Comments by Guggenheim for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -13.41%
Target price 117.800
Change
Ends at 28.02.24

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $125.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Guggenheim 
0
Report Share
28.02.23
In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) -13.41%
Target price 117.800
Change
Ends at 28.02.24

Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

Guggenheim 
0
Report Share
29.02.24

Current prediction by Guggenheim for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€85.26
13.09.23
€102.48
13.09.24
-9.71%
10.09.24

Guggenheim 
13.09.23 50%